- Open Access
Cortisol secretion after adrenocorticotrophin (ACTH) and Dexamethasone tests in healthy female and male dogs
Acta Veterinaria Scandinavica volume 51, Article number: 33 (2009)
For the conclusive diagnosis of Cushing's Syndrome, a stimulating ACTH test or a low suppressive Dexamethasone test is used. Reports in other species than the dog indicate that plasma cortisol concentration after ACTH administration is affected by gender. We investigated the effect of gender on the cortisol response to ACTH and Dexamethasone tests in dogs.
Seven healthy adult Cocker Spaniels (4 females and 3 males) were assigned to a two by two factorial design: 4 dogs (2 females and 2 males) received IV Dexamethasone 0.01 mg/kg, while the other 3 dogs received an IV saline solution (control group). Two weeks later the treatments were reversed. After one month, ACTH was given IV (250 μg/animal) to 4 dogs (2 female and 2 males) while the rest was treated with saline solution (control group). Cortisol concentrations were determined by a direct solid-phase radioimmunoassay and cholesterol and triglycerides by commercial kits.
Results and Discussion
No effect of treatment was observed in metabolite concentrations, but females presented higher cholesterol concentrations. ACTH-treated dogs showed an increase in cortisol levels in the first hour after sampling until 3 hours post injection. Cortisol concentrations in Dexamethasone-treated dogs decreased one hour post injection and remained low for 3 hours, thereafter cortisol concentrations increased. The increase in cortisol levels from one to two hours post ACTH injection was significantly higher in females than males. In Dexamethasone-treated males cortisol levels decreased one hour post injection up to 3 hours; in females the decrease was more pronounced and prolonged, up to 5 hours post injection.
We have demonstrated that cortisol response to ACTH and Dexamethasone treatment in dogs differs according to sex.
Cushing's Syndrome (CS) is a disorder associated with excessive glucocorticoid production. The CS is one of the most common endocrine pathologies in dogs [1, 2]. The excess of cortisol affects different tissues and metabolic pathways, such as the carbohydrate and lipid pathways [3–6]. As a result dogs show glucose intolerance, hyperglycemia and hyperlipemia accompanied with an increase in triglycerides and total cholesterol, [4, 7, 8] causing signs as polyuria, polydipsia, polyphagia and abdominal enlargement. All characteristics of Cushing's Syndrome [9, 10].
Even though it is possible to diagnose CS by clinical signs, laboratory tests and radiology/ecography exams, the syndrome should be confirmed by hormone determination . Determination of basal cortisol is of no meaning, levels are very variable and affected by the stress of sampling. Thus, for the conclusive diagnosis a stimulating ACTH test or a low suppressive Dexamethasone test is used . The suggested hours for sampling after ACTH administration are 30 to 60 min post-injection and for the low dose Dexamethasone test 3 to 4 and 8 hours after the injection .
Many laboratories have established reliable reference values for cortisol concentrations in blood of clinically normal animals. However, non pathologic factors that affect adrenocortical secretion may lead to misinterpretation of test results. For other species (humans, ruminants) a gender effect on cortisol concentrations exists , but in dogs no sex effect has been found . In sheep, plasma cortisol concentrations after ACTH administration were higher in females than in males . Cortisol affects carbohydrate and lipid metabolism, and even if it is known that ACTH/Dexamethasone administration affects cortisol levels, we found no reports on their effects on cholesterol and triglycerides levels in dogs.
The aim of this study was to determine the effect of ACTH and the low-dose Dexamethasone test on cortisol concentrations determined hourly in healthy male and female dogs. We also investigated the effects of these tests on cholesterol and triglycerides levels.
Materials and methods
Animals and blood sampling
Seven healthy adult Cocker Spaniels, 6 to 9 years of age (3 males and 4 females) were used. The mean (± SEM) weight of these animals was 9 ± 0.7 kg. Animals were fed with a commercial diet (Excelent, Purina, Nestlé, Buenos Aires, Argentina) at 20:00 hours. Animal experimentation was performed in compliance with regulations set by the Veterinary Faculty, University of Uruguay, Uruguay.
Animal management and blood sampling was the same in both experimental designs. Animals were catheterized in the cephalic vein at 6:00 and blood samples were taken every hour from 7:00 until 17:00 hours in heparinized vials. Infusions of ACTH, Dexamethasone or saline solutions were given at 9:00 (e.g. two hours after the initiation of the blood sampling). Blood samples were centrifuged at 3000 rpm for 15 min and plasma was stored at -20°C until assayed.
Experimental Design 1: Low-dose Dexamethasone test
A cross-over design was performed: Dexamethasone 0.01 mg/kg (Dispert S.A., Montevideo, Uruguay) was given IV to four dogs (2 females and 2 males), while the other 3 dogs received IV saline solution. Two weeks later, the Dexamethasone-treated animals received the IV saline solution, while the previous control dogs were treated with the same Dexamethasone dose.
Experimental Design 2: ACTH test
ACTH was given IV at a dose of 250 μg/animal (Novartis Farmaceutica LTD, England) to 4 dogs (2 females and 2 males) while the rest received saline solution (control group).
Plasma samples were assayed in the Laboratory of Nuclear Techniques, Veterinary Faculty, Montevideo, Uruguay.
Cortisol concentrations were determined by a direct solid-phase radioimmunoassay using DPC kits (Diagnostic Products Corporation, Los Angeles, CA, USA). The analytical detection limit of the assay was 9.6 nmol/L. The intra-assay coefficients of variation for low (27.6 nmol/L) and medium controls (138.0 nmol/L) were 3.4% and 5.3%, respectively. The inter-assay coefficients of variation for the same controls were 8.7% and 7.6%, respectively.
The methods and commercial kits used were: Cholesterol by enzymatic AA method (Wiener Lab 1220114, Rosario-Argentina) and Triglycerides by GPO/PAP AA Wiener Lab 1780112, Rosario-Argentina). The standatrol was used as an internal control (Wiener Lab 1937553, Rosario-Argentina). The intra-assay coefficient of variation was below 10%.
Cortisol, cholesterol and triglycerides concentrations were analyzed by the mixed procedure (PROC MIXED de SAS®, Statistical Analysis System, SAS Institute Inc., Cary, NC, USA 2000). The statistical model included the effects of treatment, gender and hour of sampling and their interactions. Data are presented in graphs as least square means ± pooled standard error. Significance was considered when P ≤ 0.05, and values between P > 0.05 and P < 0.1 were considered a trend.
Sampling time, treatment and their interaction had a significant effect on cortisol concentrations (P < 0.0001 for all effects). Cortisol concentrations in Dexamethasone treated dogs decreased one hour post injection and remained low for 3 hours, thereafter cortisol concentrations increased. ACTH-test dogs showed an increase in cortisol levels in the first hour after sampling until 3 hours post injection. No differences from basal levels were found 4 hours post injection (Figure 1). No effect of time of sampling on cortisol levels were observed in control dogs (Figure 1). No effect of sampling on cholesterol levels were observed, but triglyceride concentrations decreased at the end of the sampling period (Figure 2).
A significant interaction between sex*treatment (P < 0.0001) and sex*treatment*time of sampling (P = 0.0095) on cortisol concentrations were found. In the Dexamethasone-treated males cortisol levels decreased one hour post injection and returned to pre-treatment levels 3 hours later. In the females the decrease was more pronounced and prolonged, returning to pre-treatment levels 6 hours post injection (Figure 3A). This resulted in that cortisol levels were lower in females 4 and 5 hours after Dexamethasone injection. The increase in cortisol levels from one to two hours post ACTH injection was significantly higher in females than males (P < 0.001) (Figure 3B). Control dogs did not show differences among gender (Figure 3C).
There was an effect of gender on cholesterol and triglycerides concentrations, as females had higher cholesterol levels (6.2 ± 0.26 vs 5.2 ± 0.26 mmol/L, P < 0.0001) and triglycerides concentrations (0.91 ± 0.08 vs 0.80 ± 0.07 mmol/L respectively). Since there was no effect of treatment or sampling time on metabolite concentrations, data was pooled according to gender (Figure 2).
A circadian rhythm for cortisol secretion has been reported for humans, monkeys and rats, but this is contradictory in dogs [15–17]. In the present study, cortisol concentrations were measured hourly for 10 hours and no variations were observed. No changes were found in cholesterol concentrations, but triglycerides levels decreased at the end of the experimental period probably due to the prolonged time from the last meal (17 hours after intake).
No effect of treatment was observed in cortisol concentrations. Dexamethasone-treated dogs presented a decrease in the first hour post injection that lasted until 3 hours post injection. Feldman and Nelson  found a similar suppression of cortisol secretion after Dexamethasone treatment in dogs sampled hourly, although the levels remained low up to 8 hours post injection. This difference cannot be attributed to the dose, but it could be due to the adjuvant and/or management of the animals (e.g., breed, hours of fasting). Cortisol response to stimulation with ACTH and inhibition with Dexamethasone was similar to other reports considering not only the maximum cortisol concentrations after treatment, but also the duration of the response [18–20]. In the present study, ACTH-treated dogs maintained high cortisol levels up to 3 hours post injection; while Hansen et al (1994) -sampling every 30 min- found a significant increase, similar to ours, in the first 30 min post-injection and a maximum concentration 1.5 hours after injection. Their sampling ended at 2.5 hours and cortisol concentrations were - although lower than 1.5 hour post injection- still different from baseline.
Although our study used a small number of animals, it should be noted that the frequent sampling and cortisol concentrations could not be attributed to the stress of the sampling procedure. We did not find sex differences in basal cortisol levels, which is in agreement with Reimers et al. 1990  who did not find any effect of gender on cortisol concentrations in healthy dogs. On the other hand, the concentration of the precursor of cortisol - cholesterol - was higher in female dogs than males (6.2 vs 5.2 mmol/L), in agreement with Barrie et al 1993 .
This study showed that gender affected the cortisol response of the animals when stimulated with ACTH or inhibited with Dexamethasone.
Dexamethasone inhibition of cortisol secretion differed according to sex, as inhibition lasted longer in females than in males. We have not found any reports on different response by gender in Dexamethasone-treated dogs. In humans, the glucocorticoid sensitivity measured by a Dexamethasone suppression test and the combined Dexamethasone suppression/CRH stimulation (Dex-CRH) test used to evaluate the degree of HPA-axis dysregulation in patients with unipolar depression have been shown to be affected by sex . Moreover, in rats, estrogen treatment reduced type I receptors in the anterior pituitary by 50-60%; this down-regulatory effect was seen only in female rats and no change was found for males suggesting that the regulation was steroid independent . Whether the prolonged Dexamethasone inhibition on cortisol secretion in dogs is due to differential pituitary/hypothalamus sensitivity to glucocorticoids remains to be elucidated.
ACTH response - in terms of cortisol secretion - was also affected by gender as females presented higher cortisol concentrations than males. This is in agreement with reports in other species (rat [24, 25]; sheep in vitro ; sheep in vivo ). Since the treatment was with exogenous ACTH, we can suggest that the peripheral response of the adrenal glands to ACTH has a different regulation among sexes. We have found no reports on different sensitivity of the adrenal gland to ACTH in dogs. On the other hand, we have previously shown the existence of estrogen receptor alpha (ERα) in the sheep adrenal gland and found a varying sensitivity to oestrogens as the ER levels differed according to sex and gonadal status, with the ewes having higher ER levels than rams . These findings indicate that oestrogens most likely affect steroidogenesis directly at the adrenal cortex and suggest that oestrogens are partly responsible for the sex differences in cortisol secretion in sheep. Possible mechanisms by which oestrogens might affect adrenal steroidogenesis have been suggested: influence on adrenocortical sensitivity to ACTH [28, 29]; stimulatory effect on the induction of enzymes in the synthesis of glucocorticoids ; and/or increase in availability of steroid precursor (cholesterol) by affecting the steroidogenic acute regulatory (StAR) protein [31, 32]. In this study the plasma concentrations of the steroid precursor - cholesterol - in female dogs was higher than in males (Figure 2A), as previously shown in the Beagle breed . This finding suggests that the higher cortisol levels found in females after ACTH test is due -at least partially- to a higher availability of its precursor: cholesterol. We have not found any studies on the mechanisms by which oestrogens participate in the regulation of adrenal cortex functions, e.g. cortisol secretion, in dogs.
In summary, we have demonstrated that the cortisol response to ACTH and Dexamethasone treatment in dogs differs according to sex.
Feldman EC: Comparison of ACTH response and Dexamethasone suppression as screening test in canine hyperadrenocorticism. J Am Vet Med Assoc. 1983, 182: 506-510.
Zerbe CA: Differentiating tests to evaluate hyperadrenocorticism in dogs and cats. Small Animal/Exotics. 2000, 22: 149-158.
Rijnberk A: Clinical Endocrinology of dogs and cats. 2002, Kluwer: Academic Pub, The Netherlands
Beale EG, Hamme RE, Antoine B, Forest C: Disregulated glyceroneogenesis: PCK1 as a candidate diabetes and obesity gene. Trends Endocrinol Metab. 2004, 15: 129-135. 10.1016/j.tem.2004.02.006.
Wake DJ, Walker BR: 11-Hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Mol Cell Endocrinol. 2004, 215: 45-54. 10.1016/j.mce.2003.11.015.
Klein J, Perwitz N, Kraus D, Fasshauer M: Adipose tissue as source and target for novel therapies. Trends Endocrinol Metab. 2006, 17: 26-32. 10.1016/j.tem.2005.11.008.
Ling GV, Stabenfeldt GH, Comer KM, Gribble DH, Schechter RD: Canine hyperadrenocorticism: pretreatment clinical and laboratory evaluation of 117 cases. J Am Vet Med Assoc. 1979, 174: 1211-1215.
Boscaro M, Barzon L, Fallo F, Sonino N: Cushing's syndrome. Lancet. 2001, 357: 783-791. 10.1016/S0140-6736(00)04172-6.
Kooistra HS: The Diagnostic Approach of Hypercortisolism in Dogs and Cats. 31st World Small Animal Veterinary Congress. 2006, ; October 11-14, Prague, Czech Repulic
Herrtage M: Hiperadrenocorticismo canino. En Manual de Endocrinología en pequeños animales. Edited by: Mooney CT y Peterson ME. 2007, Industrias Gráficas Ferre Olsina, España, 217-247. 3
Behrend EN, Kemppainen RJ: Diagnosis of Canine Hyperadrenocorticisim. Vet Clin North Am Small Anim Pract. 2001, 31: 985-1003.
Woods SC, Gotoh K, Clegg DJ: Gender difference in the control of energy homeostasis. Exp Biol Med (Maywood). 2003, 228: 1175-1180.
Reimers TJ, Lawler DF, Sutaria PM, Correa MT, Erb HN: Effects of age, sex, and body size on serum concentrations of thyroid and adrenocortical hormones in dogs. Am J Vet Res. 1990, 51: 454-457.
van Lier E, Pérez-Clariget R, Forsberg M: Sex differences in cortisol after administration of an ACTH analogue in sheep during the breeding and non breeding season. Anim Reprod Sci. 2003, 79: 81-92. 10.1016/S0378-4320(03)00083-6.
Kemppainen RJ, Sartin RL: Evidence for episodic but not circadian activity in plasma concentrations of adrenocorticotrophin, cortisol and thyroxine in dogs. J Endocrinol. 1984, 103: 219-225. 10.1677/joe.0.1030219.
Orth DN, Peterson ME, Drucker WD: Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Cushing's syndrome: diurnal rhythm and responses to various stimuli. Endocrinol. 1988, 22: 1250-1262. 10.1210/endo-122-4-1250.
Castillo VA, Cabrera Blatter MF, Gómez NV, Sinatra V, Gallelli MF, Ghersevich MC: Diurnal ACTH and plasma cortisol varations in healthy dogs and in those with pituitary-dependent Cushing's syndrome before and after treatment with retinoic acid. Res Vet Sci. 2009, 86: 223-229. 10.1016/j.rvsc.2008.06.006.
Feldman EC, Nelson RW: Hiperadrenocorticism canine (Cushing's Syndrome). Canine and feline endocrinology and reproduction. Edited by: Feldman EC, Nelson RW. 2007, Inter-Médica, Buenos Aires, República Argentina, Chapter 6: 341-345. 3
Hansen B, Kemppainen RJ, MacDonald JM: Synthetic ACTH (Cosyntropin) stimulation test in normal dogs: Comparison of intravenous and intramuscular administration. J Am Anim Hosp Assoc. 1994, 30-38.
Peterson ME, Wallace MS, Kerl ME: Dose-response relation between plasma concentrations of ACTH and cortisol after administration of incremental doses of cosyntropin for ACTH stimulation testing in dogs [abstract]. J Vet Intern Med. 1996, 10: 186-
Barrie J, Watson TDG, Stear MJ, Nash AS: Plasma cholesterol and lipoprotein concentrations in the dog: The effects of age, breed, gender and endocrine disease. J Small Anim Pract. 1993, 34: 507-512. 10.1111/j.1748-5827.1993.tb03523.x.
Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F: HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients. Psychoneuroendocrinology. 2009, 34: 99-109. 10.1016/j.psyneuen.2008.08.018.
Ferrini M, Magariños AM, De Nicola AF: Oestrogens down-regulate type I but not type II adrenal corticoid receptors in rat anterior pituitary. J Steroid Biochem. 1990, 35: 671-677. 10.1016/0022-4731(90)90307-E.
Kitay JI: Sex differences in adrenal cortical secretion in the rat. Endocrinology. 1961, 68: 818-824. 10.1210/endo-68-5-818.
Handa RJ, Burgess LH, Kerr JE, O'Keefe JA: Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis. Horm Behav. 1994, 28: 464-476. 10.1006/hbeh.1994.1044.
Canny BJ, O'Farrell KA, Clarke IJ, Tilbrook AJ: The influence of sex and gonadectomy on the hypothalamo-pituitary-adrenal axis of the sheep. J Endocrinol. 1999, 162: 215-225. 10.1677/joe.0.1620215.
van Lier E, Meikle A, Bielli A, Akerberg S, Forsberg M, Sahlin L: Sex differences in oestrogen receptor levels in adrenal glands of sheep during the breeding season. Domest Anim Endocrinol. 2003, 25: 373-387. 10.1016/j.domaniend.2003.08.005.
Atkinson HC, Waddell BJ: Circadian variation in basal plasma corticosterone and adrenocorticotropin in the rat: sexual dimorphism and changes across the estrous cycle. Endocrinology. 1997, 138: 3842-3848. 10.1210/en.138.9.3842.
Lo MJ, Chang LL, Wang PS: Effect of estradiol on corticosterone secretion in ovariectomized rats. J Cell Biochem. 2000, 77: 560-568. 10.1002/(SICI)1097-4644(20000615)77:4<560::AID-JCB4>3.0.CO;2-D.
Perry JE, Stalvey JRD: Gonadal steroids modulate adrenal fasciculata 3 beta-hydroxysteroid dehydrogenaseisomerase activity in mice. Biol Reprod. 1992, 46: 73-82. 10.1095/biolreprod46.1.73.
Townson DH, Wang XJ, Keyes PL, Kostyo JL, Stocco DM: Expression of the steroidogenic acute regulatory protein in the corpus luteum of the rabbit: dependence upon the luteotropic hormone, estradiol-17 beta. Biol Reprod. 1996, 55: 868-874. 10.1095/biolreprod55.4.868.
Stocco DM: StAR protein and the regulation of steroid hormone biosynthesis. Annu Rev Physiol. 2001, 63: 193-213. 10.1146/annurev.physiol.63.1.193.
Kaspar LV, Norris WP: Serum chemistry values of normal dogs (beagles): associations with age, sex, and family line. Lab Anim Sci. 1977, 27: 980-985.
We acknowledge Prof. Dr. Elize van Lier for the constructive criticism of this manuscript. Thanks to Marlene Gomez Porto for her technical support.
The authors declare that they have no competing interests.
PP lead the experimental designs and drafted the manuscript. AFF carried out the inmunoassays and metabolites assays. EC and LD contributed with the experimental designs. VC contributed with the interpretation of the data and correction of the manuscript. AM performed the statistical análisis and helped to draft the manuscript. All authors read and approved the final manuscript.
About this article
Cite this article
Pessina, P., Fernández-Foren, A., Cueto, E. et al. Cortisol secretion after adrenocorticotrophin (ACTH) and Dexamethasone tests in healthy female and male dogs. Acta Vet Scand 51, 33 (2009) doi:10.1186/1751-0147-51-33
- Cortisol Level
- Cortisol Concentration
- Post Injection